Clinical Trial Update: Fenoldopam for Prevention of Acute Kidney Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for fenoldopam to prevent acute kidney injury in patients with coronary artery disease; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Kidney Injury

Drugs mentioned

• Corlopam (fenoldopam) (fenoldopam)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN